title: Comment on Jugun et al.: The safety and efficacy of high-dose daptomycin combined with rifampicin for the treatment of Gram-positive osteoarticular infections.
authors.affiliation: Department of Orthopaedics, Qingyuan People's Hospital, Affiliated to Jinan University, No. B 24, Yinquan Road, Qingyuan City, Guangdong Province, 511500, People's Republic of China, lubjdoctor@126.com.
authors.forename: Bei-ji
authors.initials: BJ
authors.lastname: Lu
authors.forename: Zhen-gang
authors.initials: ZG
authors.lastname: Zha
authors.forename: Gui-qing
authors.initials: GQ
authors.lastname: Wang
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017576:Daptomycin / Q000627:therapeutic use*; D005260:Female; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D016459:Prosthesis-Related Infections / Q000188:drug therapy*; D012293:Rifampin / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D017576:Daptomycin; D012293:Rifampin